mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-07 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-06 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-06 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-06 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-06 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |